# Ametek Inc/: financial statements, quarterly

AME · NYSE · CIK 1037868 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ame.md) · [Financials](/companies/ame/financials.md) · [Filings](/companies/ame/filings.md) · [Insiders](/companies/ame/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ame/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,623](/filings/0001037868-24-000053.md) | [1,731 d](/filings/0001037868-26-000016.md) | [1,736](/filings/0001037868-25-000040.md) | [1,735](/filings/0001037868-25-000058.md) | [1,709](/filings/0001037868-25-000077.md) | [1,762 d](/filings/0001037868-26-000016.md) | [1,732](/filings/0001037868-26-000144.md) | [1,778](/filings/0001037868-26-000175.md) | [1,893](/filings/0001037868-25-000077.md) | [1,998 d](/filings/0001037868-26-000016.md) | [1,928](/filings/0001037868-26-000144.md) | [2,044](/filings/0001037868-26-000175.md) |
| Cost of revenue | $m | [1,021](/filings/0001037868-24-000053.md) | [1,116 d](/filings/0001037868-26-000016.md) | [1,145](/filings/0001037868-25-000040.md) | [1,110](/filings/0001037868-25-000058.md) | [1,093](/filings/0001037868-25-000077.md) | [1,117 d](/filings/0001037868-26-000016.md) | [1,107](/filings/0001037868-26-000144.md) | [1,142](/filings/0001037868-26-000175.md) | [1,207](/filings/0001037868-25-000077.md) | [1,278 d](/filings/0001037868-26-000016.md) | [1,211](/filings/0001037868-26-000144.md) | [1,309](/filings/0001037868-26-000175.md) |
| Selling, general and administrative | $m | [164](/filings/0001037868-24-000053.md) | [170 d](/filings/0001037868-26-000016.md) | [174](/filings/0001037868-25-000040.md) | [177](/filings/0001037868-25-000058.md) | [170](/filings/0001037868-25-000077.md) | [176 d](/filings/0001037868-26-000016.md) | [170](/filings/0001037868-26-000144.md) | [174](/filings/0001037868-26-000175.md) | [198](/filings/0001037868-25-000077.md) | [215 d](/filings/0001037868-26-000016.md) | [203](/filings/0001037868-26-000144.md) | [207](/filings/0001037868-26-000175.md) |
| Operating income | $m | [438](/filings/0001037868-24-000053.md) | [445 d](/filings/0001037868-26-000016.md) | [417](/filings/0001037868-25-000040.md) | [448](/filings/0001037868-25-000058.md) | [446](/filings/0001037868-25-000077.md) | [469 d](/filings/0001037868-26-000016.md) | [455](/filings/0001037868-26-000144.md) | [462](/filings/0001037868-26-000175.md) | [488](/filings/0001037868-25-000077.md) | [505 d](/filings/0001037868-26-000016.md) | [515](/filings/0001037868-26-000144.md) | [528](/filings/0001037868-26-000175.md) |
| Interest expense | $m | [18.4](/filings/0001037868-23-000056.md) | [24.1 d](/filings/0001037868-24-000009.md) | [35.3](/filings/0001037868-24-000030.md) | [30.6](/filings/0001037868-25-000058.md) | [25.1](/filings/0001037868-25-000077.md) | [22.0 d](/filings/0001037868-26-000016.md) | [19.0](/filings/0001037868-26-000144.md) | [16.9](/filings/0001037868-26-000175.md) | [22.5](/filings/0001037868-25-000077.md) | [22.9 d](/filings/0001037868-26-000016.md) | [20.9](/filings/0001037868-26-000144.md) | [30.1](/filings/0001037868-26-000175.md) |
| Income tax | $m | [73.1](/filings/0001037868-24-000053.md) | [74.1 d](/filings/0001037868-26-000016.md) | [70.4](/filings/0001037868-25-000040.md) | [79.3](/filings/0001037868-25-000058.md) | [78.6](/filings/0001037868-25-000077.md) | [57.1 d](/filings/0001037868-26-000016.md) | [82.5](/filings/0001037868-26-000144.md) | [83.8](/filings/0001037868-26-000175.md) | [76.5](/filings/0001037868-25-000077.md) | [75.4 d](/filings/0001037868-26-000016.md) | [93.6](/filings/0001037868-26-000144.md) | [85.5](/filings/0001037868-26-000175.md) |
| Net income | $m | [340](/filings/0001037868-24-000053.md) | [343 d](/filings/0001037868-26-000016.md) | [311](/filings/0001037868-25-000040.md) | [338](/filings/0001037868-25-000058.md) | [340](/filings/0001037868-25-000077.md) | [387 d](/filings/0001037868-26-000016.md) | [352](/filings/0001037868-26-000144.md) | [358](/filings/0001037868-26-000175.md) | [371](/filings/0001037868-25-000077.md) | [399 d](/filings/0001037868-26-000016.md) | [399](/filings/0001037868-26-000144.md) | [407](/filings/0001037868-26-000175.md) |
| Diluted EPS | $ per share | [1.47](/filings/0001037868-24-000053.md) | not reported | [1.34](/filings/0001037868-25-000040.md) | [1.45](/filings/0001037868-25-000058.md) | [1.47](/filings/0001037868-25-000077.md) | not reported | [1.52](/filings/0001037868-26-000144.md) | [1.55](/filings/0001037868-26-000175.md) | [1.60](/filings/0001037868-25-000077.md) | not reported | [1.74](/filings/0001037868-26-000144.md) | [1.77](/filings/0001037868-26-000175.md) |
| Basic EPS | $ per share | [1.48](/filings/0001037868-24-000053.md) | not reported | [1.35](/filings/0001037868-25-000040.md) | [1.46](/filings/0001037868-25-000058.md) | [1.47](/filings/0001037868-25-000077.md) | not reported | [1.52](/filings/0001037868-26-000144.md) | [1.55](/filings/0001037868-26-000175.md) | [1.61](/filings/0001037868-25-000077.md) | not reported | [1.74](/filings/0001037868-26-000144.md) | [1.78](/filings/0001037868-26-000175.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0001037868-23-000056.md) | [0.4](/filings/0001037868-25-000012.md) | [0.4](/filings/0001037868-24-000030.md) | [0.4](/filings/0001037868-24-000048.md) | [0.4](/filings/0001037868-24-000053.md) | [0.4](/filings/0001037868-26-000016.md) | [0.4](/filings/0001037868-25-000040.md) | [0.6](/filings/0001037868-25-000058.md) | [0.4](/filings/0001037868-25-000077.md) | [0.5](/filings/0001037868-26-000175.md) | [0.5](/filings/0001037868-26-000144.md) | [0.5](/filings/0001037868-26-000175.md) |
| Current assets | $bn | [3.1](/filings/0001037868-23-000056.md) | [2.8](/filings/0001037868-25-000012.md) | [2.8](/filings/0001037868-24-000030.md) | [2.8](/filings/0001037868-24-000048.md) | [2.7](/filings/0001037868-24-000053.md) | [2.6](/filings/0001037868-26-000016.md) | [2.8](/filings/0001037868-25-000040.md) | [3.1](/filings/0001037868-25-000058.md) | [3.1](/filings/0001037868-25-000077.md) | [3.0](/filings/0001037868-26-000175.md) | [3.1](/filings/0001037868-26-000144.md) | [3.2](/filings/0001037868-26-000175.md) |
| Total assets | $bn | [13.1](/filings/0001037868-23-000056.md) | [15.0](/filings/0001037868-26-000016.md) | [14.9](/filings/0001037868-25-000040.md) | [14.8](/filings/0001037868-25-000058.md) | [14.8](/filings/0001037868-25-000077.md) | [14.6](/filings/0001037868-26-000016.md) | [14.9](/filings/0001037868-26-000144.md) | [15.3](/filings/0001037868-26-000175.md) | [16.2](/filings/0001037868-25-000077.md) | [16.1](/filings/0001037868-26-000175.md) | [16.3](/filings/0001037868-26-000144.md) | [16.6](/filings/0001037868-26-000175.md) |
| Current liabilities | $bn | [1.7](/filings/0001037868-23-000056.md) | [2.9](/filings/0001037868-25-000012.md) | [2.5](/filings/0001037868-24-000030.md) | [2.2](/filings/0001037868-24-000048.md) | [2.0](/filings/0001037868-24-000053.md) | [2.1](/filings/0001037868-26-000016.md) | [2.0](/filings/0001037868-25-000040.md) | [1.9](/filings/0001037868-25-000058.md) | [2.6](/filings/0001037868-25-000077.md) | [2.8](/filings/0001037868-26-000175.md) | [2.8](/filings/0001037868-26-000144.md) | [2.7](/filings/0001037868-26-000175.md) |
| Total liabilities | $bn | [4.8](/filings/0001037868-23-000056.md) | [6.3](/filings/0001037868-25-000012.md) | [5.9](/filings/0001037868-24-000030.md) | [5.5](/filings/0001037868-24-000048.md) | [5.2](/filings/0001037868-24-000053.md) | [5.0](/filings/0001037868-26-000016.md) | [4.9](/filings/0001037868-25-000040.md) | [4.9](/filings/0001037868-25-000058.md) | [5.7](/filings/0001037868-25-000077.md) | [5.4](/filings/0001037868-26-000175.md) | [5.4](/filings/0001037868-26-000144.md) | [5.3](/filings/0001037868-26-000175.md) |
| Long-term debt | $bn | [1.9](/filings/0001037868-23-000056.md) | [1.9](/filings/0001037868-25-000012.md) | [1.9](/filings/0001037868-24-000030.md) | [1.8](/filings/0001037868-24-000048.md) | [1.8](/filings/0001037868-24-000053.md) | [1.4](/filings/0001037868-26-000016.md) | [1.5](/filings/0001037868-25-000040.md) | [1.5](/filings/0001037868-25-000058.md) | [1.4](/filings/0001037868-25-000077.md) | [1.1](/filings/0001037868-26-000175.md) | [1.1](/filings/0001037868-26-000144.md) | [1.1](/filings/0001037868-26-000175.md) |
| Current portion of debt | $bn | [0.3](/filings/0001037868-23-000056.md) | [1.4](/filings/0001037868-25-000012.md) | [1.1](/filings/0001037868-24-000030.md) | [0.8](/filings/0001037868-24-000048.md) | [0.6](/filings/0001037868-24-000053.md) | [0.7](/filings/0001037868-26-000016.md) | [0.5](/filings/0001037868-25-000040.md) | [0.4](/filings/0001037868-25-000058.md) | [1.0](/filings/0001037868-25-000077.md) | [1.2](/filings/0001037868-26-000175.md) | [1.1](/filings/0001037868-26-000144.md) | [1.0](/filings/0001037868-26-000175.md) |
| Shareholders' equity | $bn | [8.3](/filings/0001037868-24-000053.md) | [8.7](/filings/0001037868-26-000016.md) | [9.0](/filings/0001037868-25-000040.md) | [9.3](/filings/0001037868-25-000058.md) | [9.6](/filings/0001037868-25-000077.md) | [9.7](/filings/0001037868-26-000175.md) | [10.0](/filings/0001037868-26-000175.md) | [10.4](/filings/0001037868-26-000175.md) | [10.5](/filings/0001037868-25-000077.md) | [10.6](/filings/0001037868-26-000175.md) | [10.9](/filings/0001037868-26-000175.md) | [11.3](/filings/0001037868-26-000175.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [473 d](/filings/0001037868-24-000053.md) | [541 d](/filings/0001037868-26-000016.md) | [410](/filings/0001037868-25-000040.md) | [381 d](/filings/0001037868-25-000058.md) | [487 d](/filings/0001037868-25-000077.md) | [550 d](/filings/0001037868-26-000016.md) | [418](/filings/0001037868-26-000144.md) | [359 d](/filings/0001037868-26-000175.md) | [441 d](/filings/0001037868-25-000077.md) | [584 d](/filings/0001037868-26-000016.md) | [452](/filings/0001037868-26-000144.md) | [484 d](/filings/0001037868-26-000175.md) |
| Capital expenditure | $m | [28.7 d](/filings/0001037868-24-000053.md) | [59.7 d](/filings/0001037868-26-000016.md) | [27.7](/filings/0001037868-25-000040.md) | [21.4 d](/filings/0001037868-25-000058.md) | [26.3 d](/filings/0001037868-25-000077.md) | [51.7 d](/filings/0001037868-26-000016.md) | [23.1](/filings/0001037868-26-000144.md) | [29.3 d](/filings/0001037868-26-000175.md) | [20.9 d](/filings/0001037868-25-000077.md) | [57.0 d](/filings/0001037868-26-000016.md) | [25.5](/filings/0001037868-26-000144.md) | [32.0 d](/filings/0001037868-26-000175.md) |
| Dividends paid | $m | [57.6 d](/filings/0001037868-24-000053.md) | [57.6 d](/filings/0001037868-26-000016.md) | [64.7](/filings/0001037868-25-000040.md) | [64.7 d](/filings/0001037868-25-000058.md) | [64.7 d](/filings/0001037868-25-000077.md) | [64.7 d](/filings/0001037868-26-000016.md) | [71.5](/filings/0001037868-26-000144.md) | [71.5 d](/filings/0001037868-26-000175.md) | [71.4 d](/filings/0001037868-25-000077.md) | [71.0 d](/filings/0001037868-26-000016.md) | [77.8](/filings/0001037868-26-000144.md) | [77.9 d](/filings/0001037868-26-000175.md) |
| Share repurchases | $m | [0.1 d](/filings/0001037868-24-000053.md) | [1.2 d](/filings/0001037868-26-000016.md) | [6.9](/filings/0001037868-25-000040.md) | [0.7 d](/filings/0001037868-25-000058.md) | [60.4 d](/filings/0001037868-25-000077.md) | [144 d](/filings/0001037868-26-000016.md) | [18.0](/filings/0001037868-26-000144.md) | [0.1 d](/filings/0001037868-26-000175.md) | [146 d](/filings/0001037868-25-000077.md) | [270 d](/filings/0001037868-26-000016.md) | [27.9](/filings/0001037868-26-000144.md) | [0.2 d](/filings/0001037868-26-000175.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [231](/filings/0001037868-23-000056.md) | [231](/filings/0001037868-24-000030.md) | [231](/filings/0001037868-24-000048.md) | [232](/filings/0001037868-24-000053.md) | [232](/filings/0001037868-25-000040.md) | [232](/filings/0001037868-25-000058.md) | [232](/filings/0001037868-25-000077.md) | [232](/filings/0001037868-26-000144.md) | [231](/filings/0001037868-26-000175.md) | [232](/filings/0001037868-25-000077.md) | [230](/filings/0001037868-26-000144.md) | [230](/filings/0001037868-26-000175.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 229,261,244 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001037868-26-000175.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.